Neurogene (Neurogene) Other Long Term Assets : $1.17 Mil (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Neurogene Other Long Term Assets?

Neurogene's other long-term assets for the quarter that ended in Mar. 2024 was $1.17 Mil.

Neurogene's quarterly other long-term assets declined from Sep. 2023 ($3.17 Mil) to Dec. 2023 ($1.37 Mil) but then stayed the same from Dec. 2023 ($1.37 Mil) to Mar. 2024 ($1.17 Mil).

Neurogene's annual other long-term assets increased from Dec. 2021 ($-0.00 Mil) to Dec. 2022 ($0.09 Mil) and increased from Dec. 2022 ($0.09 Mil) to Dec. 2023 ($1.37 Mil).

Neurogene Other Long Term Assets Historical Data

The historical data trend for Neurogene's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neurogene Other Long Term Assets Chart

Neurogene Annual Data

Trend

Dec21

Dec22

Dec23

Other Long Term Assets

0.09

1.37

Neurogene Quarterly Data
	Dec21	Jun22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Long Term Assets	Get a 7-Day Free Trial			-	0.74	3.17	1.37	1.17

Neurogene Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Neurogene (Neurogene) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Neurogene Inc (NAS:NGNE) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

535 W 24th Street, 5th Floor, New York, NY, USA, 10011

Website

https://www.neurogene.com

Neurogene Inc is a clinical stage biotechnology company whose objective is to harness the power of gene therapy which is combined with its EXACT gene regulation technology to turn today's complex devastating neurological diseases into treatable conditions.

Neurogene (Neurogene) Headlines

From GuruFocus

Neurogene Announces Business Update and 2024 Outlook

By Business Wire • 01-05-2024

Neurogene Announces Closing of Merger with Neoleukin Therapeutics and Concurrent Private Placement of $95 Million

By Business Wire • 12-19-2023